Aims To evaluate the frequency of impaired glucose tolerance (IGT) and undiagnosed diabetes mellitus together with the indices of insulin resistance (IR) in primary hyperparathyroidism (pHPT).
Introduction
The prevalence of diabetes mellitus and insulin resistance are increased in patients with primary hyperparathyroidism (pHPT) [1] [2] [3] [4] , probably contributing to their increased risk of cardiovascular disease [5, 6] . However, previous studies in small or surgical pHPT series reported contradictory data reporting prevalence of impaired glucose tolerance (IGT, 10.2-50%) and undiagnosed diabetes mellitus (6.4%), respectively, based on different methods [3, 7, 8] .
In a large and modern day pHPT series, which consisted mostly of asymptomatic patients, we evaluated the prevalence of IGT and undiagnosed diabetes using the oral glucose tolerance test (OGTT) plus indices of insulin resistance. The influence of the clinical presentation of pHPT on glucose metabolism was also investigated.
Subjects and methods
Diagnosis of pHPT was confirmed by the presence of hypercalcaemia and concomitant inappropriately raised serum intact parathormone (PTH) levels, whereas that of diabetes or IGT was based on American Diabetes Association criteria [9] .
Out of 105 consecutive patients with pHPT (F/M 78/27, asymptomatic/symptomatic 68/37, age (mean ± SD ) 60.7 ± 12.7 years, body mass index (BMI) 25.2 ± 3.8 kg/m 2 , ionized calcium (iCa) 1.49 ± 0.16 mmol / l, PTH 200.4 ± 233.9 pg / ml), 15 patients with known diabetes were excluded from the study, as were another 31 patients who refused to give consent. Moreover, another two patients with MEN-1 were kept out of the analysis.
The clinical and biochemical characteristics of pHPT patients and controls studied are shown in Table 1 . There were no differences in clinical and biochemical characteristics between patients without known diabetes who underwent OGTT and those who did not (24 F/7 M, asymptomatic/symptomatic 21/10, age (median, 95% confidence intervals (CI)), 59.0, 56.3-65.4 years, BMI 24.0, 22.5-25.3 kg / m 2 , iCa 1.44, 1.45-1.54 mmol / l, PTH 125, 113.5-274 pg/ml). Radiological signs of bone involvement or nephrolithiasis characterized symptomatic pHPT.
Control subjects were selected from consecutive in-patients attending our clinic whose age, sex, BMI and other risk factors for diabetes were matched to pHPT patients in order to perform a case-control cross-sectional study (Table 1) . They had diseases clearly established as not influencing glucose tolerance and insulin sensitivity, i.e. non-toxic uninodular ( n = 15) or multinodular ( n = 21) goitre, idiopathic osteoporosis ( n = 13) and Paget's disease ( n = 4) apart from 15 obese patients included for matching requirements. All subjects gave their informed consent prior to entering the study. They were on free diet for at least 3 days before being administered OGTT (75 g) and were free from treatment with drugs influencing glucose metabolism.
A previously published population OGTT study was also included to provide normative values of prevalence of classes of glucose intolerance [10] .
Indices of insulin resistance were derived from homeostasis model assessment (HOMA IR ) and OGTT data (insulin sensitivity index composite (ISI comp)) [11, 12] .
Serum total calcium (Ca) and phosphate (P) were assayed by automated analysis using colorimetric and enzymatic methods, serum iCa by a specific probe after correction for pH, serum PTH concentrations were measured using a two-site immunoradiometric (IRMA) assay with an inter-and intra-assay coefficient of variation of < 5%. Serum insulin ( µ U/ml) was measured by an immunenzymometric assay. The sensitivity of the insulin assay was 2 µ U/ml and the inter-and intra-assay coefficients of variation were 5.8-7.0% and 3.5-4.6%, respectively. Plasma glucose levels (mg /dl) were measured by an enzymatic colorimetric test.
Data are presented as means ± SD or as means (or medians, for non-normal data) and 95% CI where differences are contrasted. Normality of frequency distribution functions was tested by the Shapiro-Wilk W -test. Significant differences were sought by the Mann-Whitney U -test or χ 2 analysis, using 
Results
The prevalence of IGT was higher in pHPT patients than in controls (mean, 95% CI, 40.7%, 27.8-53.6 vs. 25.0%, 13.7-36.3, respectively; P < 0.03) ( Table 1) . Similarly, the prevalence of undiagnosed diabetes was higher in pHPT than in controls (15.3%, 5.8 -24.7 vs. 5%, 0 -10.7, respectively; P < 0.05) ( Table 1) . Moreover, in pHPT the prevalence of IGT or undiagnosed or known diabetes (14.3%, 7.5 -21) was higher than that reported in the general population (8.5%, 7.4 -9.5 or 3.2%, 2.5 -3.9 or 8.2%, 7.1 -9.2, respectively). A similar increase in the prevalence of altered glucose tolerance was found both in asymptomatic and symptomatic patients. Levels of statistical significance were attained only for the comparison of the asymptomatic form with controls, but not for the symptomatic one, due to the small size of this group (Table 1) . Moreover, there was a trend towards an age difference between symptomatic and asymptomatic patients ( P = 0.06) ( Table 1) . On the other hand, seven out of 59 pHPT patients (11.9%, 3.4 -20.4) and five out of 60 control subjects (8.3%, 1.1-15.5) had impaired fasting glycaemia, while IGT was concomitantly present in 2/7 patients and 1/5 controls.
ISI comp and HOMA IR showed an increased insulin resistance in both whole pHPT group and separate clinical variants, when compared with controls (Table 1) . Moreover, glucose levels were higher in pHPT than in controls both at baseline and 90 min and 120 min after OGTT ( P < 0.05 for all comparisons), while insulin levels were higher in the former than in the latter at baseline and 60 or 90 and 120 min after OGTT ( P < 0.05 for all comparisons) ( Table 2 ).
There were no differences for either serum PTH (median, CI, 143.0, 128.8-219.4 vs. 127.5, 109.2-337.9 pg /ml, P = NS) or iCa ( ; P = NS) between pHPT patients with normal and altered glucose tolerance, respectively, while the former were less aged than the latter (55, 47.7 -59.2 vs. 62.0, 59.1-66.7 years, respectively; P < 0.014).
There was a significant correlation between ISI comp and BMI both in pHPT (R = − 0.27, P < 0.05) and controls (R = − 0.56, P < 0.0003).
Discussion
In our pHPT series, using the OGTT, we demonstrate a high prevalence of both IGT and undiagnosed diabetes. Including those with known diabetes, we found overall prevalence of 70% for altered glucose tolerance in pHPT. To our knowledge this is the first report of a modern day pHPT series with a preponderance of asymptomatic patients. One explanation of these data compared with previous studies is that OGTT has a higher sensitivity in the diagnosis of IGT or undiagnosed diabetes than fasting blood glucose [13] . In our series the prevalence of known diabetes was also higher than that previously reported [1] , probably due to the large number of diabetic in-patients who attend our clinic and in whom pHPT is more likely to be diagnosed [14] . The frequency of IGT and undiagnosed diabetes was increased in our patients when compared with either control subjects or normative data obtained in the general population of Northern Italy [10] . The reliability of our data is strengthened by our finding that the frequency of IGT or undiagnosed diabetes was also higher in our controls than in the general population.
The increased prevalence of diabetes and IGT may contribute to the high cardiovascular mortality and morbidity in pHPT [5, 6] . Furthermore, our data show that clinical presentation of pHPT and disease severity are not closely related to glucose tolerance and insulin sensitivity. In fact, glucose intolerance was similarly distributed in both asymptomatic and symptomatic patients, although this was not significantly different in the second group, probably due to small numbers. It is noteworthy that patients with asymptomatic pHPT demonstrated impaired glucose metabolism. Asymptomatic pHPT is most frequently identified following routine determination of serum calcium. The ideal therapeutic approach to asymptomatic pHPT is still debated [15, 16] and the altered glucose metabolism could help to determine treatment. It has been hypothesized that pHPT leads to reduced insulin sensitivity and subsequent alterations in glucose tolerance [2] [3] [4] . However, a relationship of abnormal calcium metabolism (reflected in serum parathormone, calcium and phosphate levels) to indices of insulin sensitivity or glucose intolerance has not been demonstrated [3] . We also failed to show any differences of serum calcium, PTH and phosphate levels between pHPT patients with or without glucose intolerance. Nor did we find any relationship between serum calcium, PTH and phosphate levels and markers of insulin resistance or glucose tolerance. Duration of disease could have a pathogenic role in the development of abnormal glucose metabolism, but cannot be estimated precisely in both clinical variants of pHPT.
